As of 2025-05-16, the Net Margin of ADMA Biologics Inc (ADMA) is 46.4%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | 46.4% |
2023-12-31 | -10.9% |
2022-12-31 | -42.8% |
2021-12-31 | -88.5% |
2020-12-31 | -179.4% |
2019-12-31 | -164.8% |
2018-12-31 | -386.5% |
2017-12-31 | -192.1% |
2016-12-31 | -182.2% |
2015-12-31 | -250% |